Concepedia

Malin Boremalm

MB

Statistics

Publications

5

Citations

316

H-Index

5

Active since

2018

Affiliations

Karolinska Institutet(Current)

Umeå University

Danderyds sjukhus

University of Gothenburg

Malin Boremalm is an author at Karolinska Institutet specializing in multiple sclerosis pharmacotherapy, multiple sclerosis therapy, and multiple sclerosis.

ORCID

Publications per year

2018–2024

5

Publications

5

Comparative Effectiveness of Rituximab and Other Initial Treatment Choices for Multiple Sclerosis

Mathias Granqvist, Malin Boremalm, Amyar Poorghobad et al. · JAMA Neurology · 2018 · 212 citations · Full text

, , +13

Discontinuation and dose reduction of rituximab in relapsing–remitting multiple sclerosis

Malin Boremalm, Peter Sundström, Jonatan Salzer · Journal of Neurology · 2021 · 43 citations · Full text

, , +11

Natalizumab, rituximab and fingolimod as escalation therapy in multiple sclerosis

Malin Boremalm, Alexander Juto, Markus Axelsson et al. · European Journal of Neurology · 2019 · 39 citations

, , +15

Risk of hypogammaglobulinemia in long-term treatment with rituximab in multiple sclerosis

Sara Hallberg, Malin Boremalm, Björn Evertsson et al. · Multiple Sclerosis Journal · 2019 · 11 citations

, , +14

Hypogammaglobulinaemia during rituximab treatment in multiple sclerosis: A Swedish cohort study

Susanna Hallberg, Björn Evertsson, Ellen Lillvall et al. · European Journal of Neurology · 2024 · 11 citations · Full text

, , +16

1–5 of 5